Phoenix Wealth Advisors Invitae Corp Transaction History

Phoenix Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $3,645 - $7,110	-248 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $340,461 - $470,568	-14,005 Reduced 98.26%	248 $7,000
Q2 2021 Jul 23, 2021	SELL	$26.09 - $40.4 $219,964 - $340,612	-8,431 Reduced 37.17%	14,253 $474,000
Q1 2021 Apr 12, 2021	SELL	$33.06 - $56.93 $236,213 - $406,764	-7,145 Reduced 23.95%	22,684 $889,000
Q4 2020 Feb 05, 2021	BUY	$39.09 - $57.4 $1.17 Million - $1.71 Million	29,829 New	29,829 $1.25 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Phoenix Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Phoenix Wealth Advisors with notifications on news.